#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prader-Willi syndrome Fungal infection HER2 gene amplification Stiff person syndrome Cholestatic pruritus Glomerulonephritis acute Systemic candida Ewing's sarcoma Tuberous sclerosis complex Candida infection Immune-mediated myasthenia gravis Idiopathic inflammatory myopathy Myeloproliferative neoplasm Alport's syndrome Haemophilia A with anti factor VIII More trials…

    Learn about Rare Diseases

    Prader-Willi syndrome – Trials in Disease Brain stem glioma – Basic Information Krabbe’s disease – Trials in Disease Andersen-Tawil syndrome Small intestine leiomyosarcoma – Life with Disease Mucopolysaccharidosis III Haemophilia A with anti factor VIII – Basic Information Synovial sarcoma metastatic – Life with Disease Glomerulonephritis membranoproliferative – Diagnostics Bronchiolitis obliterans syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SILYMARIN Allogeneic Faecal Microbiota Belumosudil Mesilate Ab-729 Elexacaftor ZIMISLECEL Cl-Ad-Msc-002 Plitidepsin Aminohippuric Acid Fluoxetine Bisoprolol Fumarate WEF-001 Fluorometholone Sodium Butyrate Ravulizumab Lasmiditan SAT-3247 OXALATE Art0380 Mesilate FG001 Sevoflurane More therapies…

    Learn about Your Condition

    Gaucher's disease type III Polycystic liver disease Lupus nephritis Pulmonary embolism Henoch-Schonlein purpura Graves' disease Primary hyperoxaluria Epicondylitis Pleomorphic liposarcoma Hepatic cancer Chronic kidney disease Cytokine release syndrome Hypertension Post procedural oedema Endometrial cancer stage I More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Obesity

  • Study of Setmelanotide for Patients with Obesity Due to Specific Genetic Variants

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Setmelanotide
    France Germany Greece The Netherlands Spain

  • Study on Liraglutide for Weight Management in Children Aged 6 to 12 with Obesity

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Liraglutide
    Belgium Portugal

  • Study on Testosterone Undecanoate Effects on Liver Fat in Obese Men with Low Testosterone and Type 2 Diabetes or Prediabetes

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hypogonadism male
    • Type 2 diabetes mellitus
    • Obesity
    Investigated Drugs:
    • Testosterone Undecanoate
    Austria

  • Study on Semaglutide for Achieving Sinus Rhythm in Patients with Obesity and Persistent Atrial Fibrillation

    Not recruiting

    3 1
    Investigated Diseases:
    • Palpitations
    • Atrial fibrillation
    • Obesity
    Investigated Drugs:
    • Semaglutide
    The Netherlands

  • Study of LY3502970 for Adults with Obesity or Overweight and Related Health Issues

    Not recruiting

    3 1
    Slovakia Spain

  • Study of Retatrutide (LY3437943) for Patients with Obesity or Overweight and Knee Osteoarthritis

    Not recruiting

    3 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Ly3437943 Sodium
    Spain
Previous Page
1 … 13 14 15 16 17 18
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!